June 30, 2025

Trial Data Indicates Cell Therapy May Reverse GA Damage

Surgical delivery of OpRegen RPE cell therapy produced sustained anatomical and functional improvements in geographic atrophy, according to 36-month data.

By Jim Gallagher, senior managing editor

June 24, 2025

Implant May Modify DR Progression

PER-001 is being developed for long-term control of diabetic retinopathy by addressing underlying ischemia.